Www.aids2014.org The HDAC inhibitor romidepsin is safe and effectively reverses HIV-1 latency in vivo as measured by standard clinical assays Ole Schmeltz.
EARLY ANTIRETROVIRAL TREATMENT HIV Cure Research Training Curriculum (CUREiculum) Early Antiretroviral (ART) Treatment Module by: Scientific Leads: Dr.
HIV Cure Research Training Curriculum Nicolas Chomont, University of Montreal Richard Jefferys, Treatment Action Group The HIV CURE training curriculum.
